Two-thirds of current cancer patients, and more than three-quarters of
Rapid development in Central Africa increases the risk of infectious disease outbreaks
The Central Africa region is experiencing rapid urbanization and economic
More than half of people in Britain, France, Italy still wrongly link autism and vaccines
One of the most frustrating misperceptions in our many studies
The hidden epidemic of compulsive hair pulling
Christina Pearson was 14 years old when she started pulling
New wave of complex street drugs puzzles emergency doctors
At a time when drug overdoses are becoming more prevalent
UK group warns hospitals could run out of drugs post Brexit
A group that represents U.K. hospitals and ambulance services has
Proposal seeks to improve assessment of drug risks
A drug policy researcher is proposing a suite of changes
Number of opioid prescriptions remains unchanged, research finds
Despite increased attention to opioid abuse, prescriptions have remained relatively
Orphazyme Announces Enrollment of First Patient in Phase III Clinical Trial of Arimoclomol for ALS
Copenhagen, August 10, 2018 – Orphazyme A/S, a biopharmaceutical company
Teen tattoos: Half of parents concerned about negative health effects, impact on employment
Seventy-eight percent of parents in a national poll had a